 | • レポートコード：QY2108PAL8887 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、147ページ • 納品方法：Eメール（納期：1日） • 産業分類：医薬品 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の当調査資料ではグローバルにおけるメサラミンの市場規模（2016年-2027年）と動向についてまとめました。中国市場については主要プレイヤーの市場シェア、メサラミンの種類別市場規模（純度≥97％、純度≥98％、純度≥99％）、用途別市場規模（メサラジン錠、メサラジンカプセル、その他）も掲載しています。他に、北米・アメリカ市場、ヨーロッパ市場、アジア太平洋・日本市場、中南米市場、中東・アフリカ市場の市場規模、グローバル市場機会・課題・リスク要因、バリューチェーン・販売チャネル、主要プレイヤーの情報なども掲載しています。 ・調査の概要 ・調査のサマリー ・世界のメサラミン市場動向 ・グローバル主要プレイヤーの競争状況・市場シェア ・世界におけるメサラミンの種類別市場規模（2016年-2027年）：純度≥97％、純度≥98％、純度≥99％ ・世界におけるメサラミンの用途別市場規模（2016年-2027年）：メサラジン錠、メサラジンカプセル、その他 ・メサラミンの中国市場分析 - メサラミンの中国市場規模（2016年-2027年） - 中国におけるメサラミンの主要プレイヤー別市場シェア - 中国におけるメサラミンの種類別市場規模：純度≥97％、純度≥98％、純度≥99％ - 中国におけるメサラミンの用途別市場規模：メサラジン錠、メサラジンカプセル、その他 ・メサラミンの北米市場（2016年-2027年） ・メサラミンのヨーロッパ市場（2016年-2027年） ・メサラミンのアジア太平洋市場（2016年-2027年） ・メサラミンの中南米市場（2016年-2027年） ・メサラミンの中東・アフリカ市場（2016年-2027年） ・主要プレイヤーの情報：Syntese A/S、Divis Laboratories、Cambrex Corporation、Ipca Laboratories、Hangzhou Brother、PharmaZell、Lianyungang Fengheng Biopharm、Lasa Loboratory、Erregierre SpA、Corden Pharma Bergamo、CTX Lifescience、Ishita Active Pharma Ingredients、YC Biotech (Jiangsu)、Xinxiang Tianfeng Fine Chemical ・市場機会・課題・リスク要因分析 ・バリューチェーン・販売チャネル分析 ・... |
Mesalamine, also known as Mesalamine, or 5-aminosalicylic acid (5-ASA), is a medication used to treat inflammatory bowel disease, including ulcerative colitis and Crohn’s disease. It is generally used for mildly to moderately severe disease. It is taken by mouth or rectally. The formulations which are taken by mouth appear to be similarly effective.
The industry’s leading manufacturers are Syntese A/S, Divis Laboratories, ipca Laboratories and Cambrex Corporation, which accounted for 23.74%, 14.71%, 6.44% and 6.35% of the global revenue share in 2019, respectively.
In terms of regions, the revenue share of Europe is the highest, reaching 41.11% in 2019.
Market Analysis and Insights: Global and China Mesalamine Market
This report focuses on global and China Mesalamine market.
In 2020, the global Mesalamine market size was US$ 151.5 million and it is expected to reach US$ 189.1 million by the end of 2027, with a CAGR of 3.2% during 2021-2027. In China the Mesalamine market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.
Global Mesalamine Scope and Market Size
Mesalamine market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Mesalamine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For China market, this report focuses on the Mesalamine market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.
Segment by Type
Purity ≥ 97%
Purity ≥ 98%
Purity ≥ 99%
Segment by Application
Mesalazine Tablets
Mesalazine Capsules
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Syntese A/S
Divis Laboratories
Cambrex Corporation
Ipca Laboratories
Hangzhou Brother
PharmaZell
Lianyungang Fengheng Biopharm
Lasa Loboratory
Erregierre SpA
Corden Pharma Bergamo
CTX Lifescience
Ishita Active Pharma Ingredients
YC Biotech (Jiangsu)
Xinxiang Tianfeng Fine Chemical
1 Study Coverage
1.1 Mesalamine Product Introduction
1.2 Market by Type
1.2.1 Global Mesalamine Market Size Growth Rate by Type
1.2.2 Purity ≥ 97%
1.2.3 Purity ≥ 98%
1.2.4 Purity ≥ 99%
1.3 Market by Application
1.3.1 Global Mesalamine Market Size Growth Rate by Application
1.3.2 Mesalazine Tablets
1.3.3 Mesalazine Capsules
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Mesalamine Market Size, Estimates and Forecasts
2.1.1 Global Mesalamine Revenue 2016-2027
2.1.2 Global Mesalamine Sales 2016-2027
2.2 Global Mesalamine, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Mesalamine Historical Market Size by Region (2016-2021)
2.3.1 Global Mesalamine Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Mesalamine Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Mesalamine Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Mesalamine Sales Forecast by Region (2022-2027)
2.4.2 Global Mesalamine Revenue Forecast by Region (2022-2027)
3 Global Mesalamine Competitor Landscape by Players
3.1 Global Top Mesalamine Manufacturers by Sales
3.1.1 Global Mesalamine Sales by Manufacturer (2016-2021)
3.1.2 Global Mesalamine Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Mesalamine Manufacturers by Revenue
3.2.1 Key Mesalamine Manufacturers Covered: Ranking by Revenue
3.2.2 Global Mesalamine Revenue by Manufacturers (2016-2021)
3.2.3 Global Mesalamine Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Mesalamine Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Mesalamine Revenue in 2020
3.2.6 Global Mesalamine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Mesalamine Price by Manufacturers
3.4 Global Mesalamine Manufacturing Base Distribution, Product Types
3.4.1 Mesalamine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Mesalamine Product Type
3.4.3 Date of International Manufacturers Enter into Mesalamine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Mesalamine Market Size by Type (2016-2021)
4.1.1 Global Mesalamine Sales by Type (2016-2021)
4.1.2 Global Mesalamine Revenue by Type (2016-2021)
4.1.3 Mesalamine Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Mesalamine Market Size Forecast by Type (2022-2027)
4.2.1 Global Mesalamine Sales Forecast by Type (2022-2027)
4.2.2 Global Mesalamine Revenue Forecast by Type (2022-2027)
4.2.3 Mesalamine Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Mesalamine Market Size by Application (2016-2021)
5.1.1 Global Mesalamine Sales by Application (2016-2021)
5.1.2 Global Mesalamine Revenue by Application (2016-2021)
5.1.3 Mesalamine Price by Application (2016-2021)
5.2 Mesalamine Market Size Forecast by Application (2022-2027)
5.2.1 Global Mesalamine Sales Forecast by Application (2022-2027)
5.2.2 Global Mesalamine Revenue Forecast by Application (2022-2027)
5.2.3 Global Mesalamine Price Forecast by Application (2022-2027)
6 China by Players, Type and Application
6.1 China Mesalamine Market Size YoY Growth 2016-2027
6.1.1 China Mesalamine Sales YoY Growth 2016-2027
6.1.2 China Mesalamine Revenue YoY Growth 2016-2027
6.1.3 China Mesalamine Market Share in Global Market 2016-2027
6.2 China Mesalamine Market Size by Players (International and Local Players)
6.2.1 China Top Mesalamine Players by Sales (2016-2021)
6.2.2 China Top Mesalamine Players by Revenue (2016-2021)
6.3 China Mesalamine Historic Market Review by Type (2016-2021)
6.3.1 China Mesalamine Sales Market Share by Type (2016-2021)
6.3.2 China Mesalamine Revenue Market Share by Type (2016-2021)
6.3.3 China Mesalamine Price by Type (2016-2021)
6.4 China Mesalamine Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Mesalamine Sales Forecast by Type (2022-2027)
6.4.2 China Mesalamine Revenue Forecast by Type (2022-2027)
6.4.3 China Mesalamine Price Forecast by Type (2022-2027)
6.5 China Mesalamine Historic Market Review by Application (2016-2021)
6.5.1 China Mesalamine Sales Market Share by Application (2016-2021)
6.5.2 China Mesalamine Revenue Market Share by Application (2016-2021)
6.5.3 China Mesalamine Price by Application (2016-2021)
6.6 China Mesalamine Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Mesalamine Sales Forecast by Application (2022-2027)
6.6.2 China Mesalamine Revenue Forecast by Application (2022-2027)
6.6.3 China Mesalamine Price Forecast by Application (2022-2027)
7 North America
7.1 North America Mesalamine Market Size YoY Growth 2016-2027
7.2 North America Mesalamine Market Facts & Figures by Country
7.2.1 North America Mesalamine Sales by Country (2016-2021)
7.2.2 North America Mesalamine Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Mesalamine Market Size YoY Growth 2016-2027
8.2 Asia Pacific Mesalamine Market Facts & Figures by Region
8.2.1 Asia Pacific Mesalamine Sales by Region (2016-2021)
8.2.2 Asia Pacific Mesalamine Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Mesalamine Market Size YoY Growth 2016-2027
9.2 Europe Mesalamine Market Facts & Figures by Country
9.2.1 Europe Mesalamine Sales by Country (2016-2021)
9.2.2 Europe Mesalamine Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Mesalamine Market Size YoY Growth 2016-2027
10.2 Latin America Mesalamine Market Facts & Figures by Country
10.2.1 Latin America Mesalamine Sales by Country (2016-2021)
10.2.2 Latin America Mesalamine Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Mesalamine Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Mesalamine Market Facts & Figures by Country
11.2.1 Middle East and Africa Mesalamine Sales by Country (2016-2021)
11.2.2 Middle East and Africa Mesalamine Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 Syntese A/S
12.1.1 Syntese A/S Corporation Information
12.1.2 Syntese A/S Description and Business Overview
12.1.3 Syntese A/S Mesalamine Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Syntese A/S Mesalamine Products Offered
12.1.5 Syntese A/S Recent Development
12.2 Divis Laboratories
12.2.1 Divis Laboratories Corporation Information
12.2.2 Divis Laboratories Description and Business Overview
12.2.3 Divis Laboratories Mesalamine Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Divis Laboratories Mesalamine Products Offered
12.2.5 Divis Laboratories Recent Development
12.3 Cambrex Corporation
12.3.1 Cambrex Corporation Corporation Information
12.3.2 Cambrex Corporation Description and Business Overview
12.3.3 Cambrex Corporation Mesalamine Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Cambrex Corporation Mesalamine Products Offered
12.3.5 Cambrex Corporation Recent Development
12.4 Ipca Laboratories
12.4.1 Ipca Laboratories Corporation Information
12.4.2 Ipca Laboratories Description and Business Overview
12.4.3 Ipca Laboratories Mesalamine Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Ipca Laboratories Mesalamine Products Offered
12.4.5 Ipca Laboratories Recent Development
12.5 Hangzhou Brother
12.5.1 Hangzhou Brother Corporation Information
12.5.2 Hangzhou Brother Description and Business Overview
12.5.3 Hangzhou Brother Mesalamine Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Hangzhou Brother Mesalamine Products Offered
12.5.5 Hangzhou Brother Recent Development
12.6 PharmaZell
12.6.1 PharmaZell Corporation Information
12.6.2 PharmaZell Description and Business Overview
12.6.3 PharmaZell Mesalamine Sales, Revenue and Gross Margin (2016-2021)
12.6.4 PharmaZell Mesalamine Products Offered
12.6.5 PharmaZell Recent Development
12.7 Lianyungang Fengheng Biopharm
12.7.1 Lianyungang Fengheng Biopharm Corporation Information
12.7.2 Lianyungang Fengheng Biopharm Description and Business Overview
12.7.3 Lianyungang Fengheng Biopharm Mesalamine Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Lianyungang Fengheng Biopharm Mesalamine Products Offered
12.7.5 Lianyungang Fengheng Biopharm Recent Development
12.8 Lasa Loboratory
12.8.1 Lasa Loboratory Corporation Information
12.8.2 Lasa Loboratory Description and Business Overview
12.8.3 Lasa Loboratory Mesalamine Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Lasa Loboratory Mesalamine Products Offered
12.8.5 Lasa Loboratory Recent Development
12.9 Erregierre SpA
12.9.1 Erregierre SpA Corporation Information
12.9.2 Erregierre SpA Description and Business Overview
12.9.3 Erregierre SpA Mesalamine Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Erregierre SpA Mesalamine Products Offered
12.9.5 Erregierre SpA Recent Development
12.10 Corden Pharma Bergamo
12.10.1 Corden Pharma Bergamo Corporation Information
12.10.2 Corden Pharma Bergamo Description and Business Overview
12.10.3 Corden Pharma Bergamo Mesalamine Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Corden Pharma Bergamo Mesalamine Products Offered
12.10.5 Corden Pharma Bergamo Recent Development
12.11 Syntese A/S
12.11.1 Syntese A/S Corporation Information
12.11.2 Syntese A/S Description and Business Overview
12.11.3 Syntese A/S Mesalamine Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Syntese A/S Mesalamine Products Offered
12.11.5 Syntese A/S Recent Development
12.12 Ishita Active Pharma Ingredients
12.12.1 Ishita Active Pharma Ingredients Corporation Information
12.12.2 Ishita Active Pharma Ingredients Description and Business Overview
12.12.3 Ishita Active Pharma Ingredients Mesalamine Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Ishita Active Pharma Ingredients Products Offered
12.12.5 Ishita Active Pharma Ingredients Recent Development
12.13 YC Biotech (Jiangsu)
12.13.1 YC Biotech (Jiangsu) Corporation Information
12.13.2 YC Biotech (Jiangsu) Description and Business Overview
12.13.3 YC Biotech (Jiangsu) Mesalamine Sales, Revenue and Gross Margin (2016-2021)
12.13.4 YC Biotech (Jiangsu) Products Offered
12.13.5 YC Biotech (Jiangsu) Recent Development
12.14 Xinxiang Tianfeng Fine Chemical
12.14.1 Xinxiang Tianfeng Fine Chemical Corporation Information
12.14.2 Xinxiang Tianfeng Fine Chemical Description and Business Overview
12.14.3 Xinxiang Tianfeng Fine Chemical Mesalamine Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Xinxiang Tianfeng Fine Chemical Products Offered
12.14.5 Xinxiang Tianfeng Fine Chemical Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Mesalamine Industry Trends
13.2 Mesalamine Market Drivers
13.3 Mesalamine Market Challenges
13.4 Mesalamine Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Mesalamine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Global Mesalamine Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Purity ≥ 97%
Table 3. Major Manufacturers of Purity ≥ 98%
Table 4. Major Manufacturers of Purity ≥ 99%
Table 5. Global Mesalamine Market Size Growth Rate by Application (2021-2027) & (MT)
Table 6. Global Mesalamine Market Size by Region (MT) & (US$ Million), 2016 VS 2021 VS 2027
Table 7. Global Mesalamine Sales by Regions (2016-2021) & (MT)
Table 8. Global Mesalamine Sales Market Share by Regions (2016-2021)
Table 9. Global Mesalamine Revenue by Regions (2016-2021) & (US$ Million)
Table 10. Global Mesalamine Sales Forecast by Region (2022-2027) & (MT)
Table 11. Global Mesalamine Sales Market Share Forecast by Region (2022-2027)
Table 12. Global Mesalamine Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 13. Global Mesalamine Revenue Market Share Forecast by Region (2022-2027)
Table 14. Global Mesalamine Sales by Manufacturers (2016-2021) (MT)
Table 15. Global Mesalamine Sales Share by Manufacturers (2016-2021)
Table 16. Ranking of Global Top Mesalamine Manufacturers by Revenue (US$ Million) in 2020
Table 17. Mesalamine Revenue by Manufacturers (2016-2021) (US$ Million)
Table 18. Mesalamine Revenue Share by Manufacturers (2016-2021)
Table 19. Global Mesalamine Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 20. Global Mesalamine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Mesalamine as of 2020)
Table 21. Key Manufacturers Mesalamine Price (2016-2021) (USD/Kg)
Table 22. Mesalamine Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Mesalamine Product Type
Table 24. Date of International Manufacturers Enter into Mesalamine Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Mesalamine Sales by Type (2016-2021) (MT)
Table 27. Global Mesalamine Sales Share by Type (2016-2021)
Table 28. Global Mesalamine Revenue by Type (2016-2021) (US$ Million)
Table 29. Global Mesalamine Revenue Share by Type (2016-2021)
Table 30. Mesalamine Average Selling Price (ASP) by Type (2016-2021) & (USD/Kg)
Table 31. Global Mesalamine Sales Forecast by Type (2022-2027) & (MT)
Table 32. Global Mesalamine Sales Market Share Forecast by Type (2022-2027)
Table 33. Global Mesalamine Revenue Forecast V (2022-2027) & (US$ Million)
Table 34. Global Mesalamine Revenue Market Share Forecast by Type (2022-2027)
Table 35. Global Mesalamine Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Kg)
Table 36. Global Mesalamine Sales by Application (2016-2021) (MT)
Table 37. Global Mesalamine Sales Share by Application (2016-2021)
Table 38. Global Mesalamine Revenue by Application (2016-2021) (US$ Million)
Table 39. Global Mesalamine Revenue Share by Application (2016-2021)
Table 40. Mesalamine Average Selling Price (ASP) by Application (2016-2021) & (USD/Kg)
Table 41. Global Mesalamine Sales Forecast by Application (2022-2027) & (MT)
Table 42. Global Mesalamine Sales Market Share Forecast by Application (2022-2027)
Table 43. Global Mesalamine Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 44. Global Mesalamine Revenue Market Share Forecast by Application (2022-2027)
Table 45. Global Mesalamine Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Kg)
Table 46. China Mesalamine Sales (MT) of Key Companies (2016-2021)
Table 47. China Mesalamine Sales Share by Company (2016-2021)
Table 48. China Mesalamine Revenue (US$ Million) by Company (2016-2021)
Table 49. China Mesalamine Revenue Share by Company (2016-2021)
Table 50. China Mesalamine Sales (MT) by Type (2016-2021)
Table 51. China Mesalamine Sales Share by Type (2016-2021)
Table 52. China Mesalamine Revenue (US$ Million) Market Share by Type (2016-2021)
Table 53. China Mesalamine Price (USD/Kg) by Type (2016-2021)
Table 54. China Mesalamine Sales (MT) by Type (2022-2027)
Table 55. China Mesalamine Sales Share by Type (2022-2027)
Table 56. China Mesalamine Revenue (US$ Million) Market Share by Type (2022-2027)
Table 57. China Mesalamine Revenue Share by Type (2022-2027)
Table 58. China Mesalamine Price (USD/Kg) by Type (2022-2027)
Table 59. China Mesalamine Sales (MT) by Application (2016-2021)
Table 60. China Mesalamine Sales Share by Application (2016-2021)
Table 61. China Mesalamine Revenue (US$ Million) Market Share by Application (2016-2021)
Table 62. China Mesalamine Price (USD/Kg) by Application (2016-2021)
Table 63. China Mesalamine Sales (MT) by Application (2022-2027)
Table 64. China Mesalamine Sales Share by Application (2022-2027)
Table 65. China Mesalamine Revenue (US$ Million) Market Share by Application (2022-2027)
Table 66. China Mesalamine Revenue Share by Application (2022-2027)
Table 67. China Mesalamine Price (USD/Kg) by Application (2022-2027)
Table 68. North America Mesalamine Sales by Country (2016-2021) & (MT)
Table 69. North America Mesalamine Sales Market Share by Country (2016-2021)
Table 70. North America Mesalamine Revenue by Country (2016-2021) & (US$ Million)
Table 71. North America Mesalamine Revenue Market Share by Country (2016-2021)
Table 72. Asia Pacific Mesalamine Sales by Region (2016-2021) & (MT)
Table 73. Asia Pacific Mesalamine Sales Market Share by Region (2016-2021)
Table 74. Asia Pacific Mesalamine Revenue by Region (2016-2021) & (US$ Million)
Table 75. Asia Pacific Mesalamine Revenue Market Share by Region (2016-2021)
Table 76. Europe Mesalamine Sales by Country (2016-2021) & (MT)
Table 77. Europe Mesalamine Sales Market Share by Country (2016-2021)
Table 78. Europe Mesalamine Revenue by Country (2016-2021) & (US$ Million)
Table 79. Europe Mesalamine Revenue Market Share by Country (2016-2021)
Table 80. Latin America Mesalamine Sales by Country (2016-2021) & (MT)
Table 81. Latin America Mesalamine Sales Market Share by Country (2016-2021)
Table 82. Latin Americaa Mesalamine Revenue by Country (2016-2021) & (US$ Million)
Table 83. Latin America Mesalamine Revenue Market Share by Country (2016-2021)
Table 84. Middle East and Africa Mesalamine Sales by Country (2016-2021) & (MT)
Table 85. Middle East and Africa Mesalamine Sales Market Share by Country (2016-2021)
Table 86. Middle East and Africa Mesalamine Revenue by Country (2016-2021) & (US$ Million)
Table 87. Middle East and Africa Mesalamine Revenue Market Share by Country (2016-2021)
Table 88. Syntese A/S Corporation Information
Table 89. Syntese A/S Description and Business Overview
Table 90. Syntese A/S Mesalamine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 91. Syntese A/S Mesalamine Product
Table 92. Syntese A/S Recent Development
Table 93. Divis Laboratories Corporation Information
Table 94. Divis Laboratories Description and Business Overview
Table 95. Divis Laboratories Mesalamine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 96. Divis Laboratories Product
Table 97. Divis Laboratories Recent Development
Table 98. Cambrex Corporation Corporation Information
Table 99. Cambrex Corporation Description and Business Overview
Table 100. Cambrex Corporation Mesalamine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 101. Cambrex Corporation Product
Table 102. Cambrex Corporation Recent Development
Table 103. Ipca Laboratories Corporation Information
Table 104. Ipca Laboratories Description and Business Overview
Table 105. Ipca Laboratories Mesalamine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 106. Ipca Laboratories Product
Table 107. Ipca Laboratories Recent Development
Table 108. Hangzhou Brother Corporation Information
Table 109. Hangzhou Brother Description and Business Overview
Table 110. Hangzhou Brother Mesalamine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 111. Hangzhou Brother Product
Table 112. Hangzhou Brother Recent Development
Table 113. PharmaZell Corporation Information
Table 114. PharmaZell Description and Business Overview
Table 115. PharmaZell Mesalamine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 116. PharmaZell Product
Table 117. PharmaZell Recent Development
Table 118. Lianyungang Fengheng Biopharm Corporation Information
Table 119. Lianyungang Fengheng Biopharm Description and Business Overview
Table 120. Lianyungang Fengheng Biopharm Mesalamine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 121. Lianyungang Fengheng Biopharm Product
Table 122. Lianyungang Fengheng Biopharm Recent Development
Table 123. Lasa Loboratory Corporation Information
Table 124. Lasa Loboratory Description and Business Overview
Table 125. Lasa Loboratory Mesalamine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 126. Lasa Loboratory Product
Table 127. Lasa Loboratory Recent Development
Table 128. Erregierre SpA Corporation Information
Table 129. Erregierre SpA Description and Business Overview
Table 130. Erregierre SpA Mesalamine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 131. Erregierre SpA Product
Table 132. Erregierre SpA Recent Development
Table 133. Corden Pharma Bergamo Corporation Information
Table 134. Corden Pharma Bergamo Description and Business Overview
Table 135. Corden Pharma Bergamo Mesalamine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 136. Corden Pharma Bergamo Product
Table 137. Corden Pharma Bergamo Recent Development
Table 138. CTX Lifescience Corporation Information
Table 139. CTX Lifescience Description and Business Overview
Table 140. CTX Lifescience Mesalamine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 141. CTX Lifescience Product
Table 142. CTX Lifescience Recent Development
Table 143. Ishita Active Pharma Ingredients Corporation Information
Table 144. Ishita Active Pharma Ingredients Description and Business Overview
Table 145. Ishita Active Pharma Ingredients Mesalamine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 146. Ishita Active Pharma Ingredients Product
Table 147. Ishita Active Pharma Ingredients Recent Development
Table 148. YC Biotech (Jiangsu) Corporation Information
Table 149. YC Biotech (Jiangsu) Description and Business Overview
Table 150. YC Biotech (Jiangsu) Mesalamine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 151. YC Biotech (Jiangsu) Product
Table 152. YC Biotech (Jiangsu) Recent Development
Table 153. Xinxiang Tianfeng Fine Chemical Corporation Information
Table 154. Xinxiang Tianfeng Fine Chemical Description and Business Overview
Table 155. Xinxiang Tianfeng Fine Chemical Mesalamine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 156. Xinxiang Tianfeng Fine Chemical Product
Table 157. Xinxiang Tianfeng Fine Chemical Recent Development
Table 158. Mesalamine Market Trends
Table 159. Mesalamine Market Drivers
Table 160. Mesalamine Market Challenges
Table 161. Mesalamine Market Restraints
Table 162. Mesalamine Customers List
Table 163. Mesalamine Distributors List
Table 164. Research Programs/Design for This Report
Table 165. Key Data Information from Secondary Sources
Table 166. Key Data Information from Primary Sources
List of Figures
Figure 1. Mesalamine Product Picture
Figure 2. Global Mesalamine Sales Market Share by Type in 2020 & 2027
Figure 3. Purity ≥ 97% Product Picture
Figure 4. Purity ≥ 98% Product Picture
Figure 5. Purity ≥ 99% Product Picture
Figure 6. Global Mesalamine Sales Market Share by Application in 2020 & 2027
Figure 7. Mesalazine Tablets
Figure 8. Mesalazine Capsules
Figure 9. Others
Figure 10. Mesalamine Report Years Considered
Figure 11. Global Mesalamine Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Mesalamine Market Size 2016-2027 (US$ Million)
Figure 13. Global Mesalamine Sales 2016-2027 (MT)
Figure 14. Global Mesalamine Market Size Market Share by Region: 2021 Versus 2027
Figure 15. Global Mesalamine Sales Market Share by Region (2016-2021)
Figure 16. Global Mesalamine Sales Market Share by Region in 2020
Figure 17. Global Mesalamine Revenue Market Share by Region (2016-2021)
Figure 18. Global Mesalamine Revenue Market Share by Region in 2020
Figure 19. Global Mesalamine Sales Share by Manufacturer in 2020
Figure 20. The Top 10 and 5 Players Market Share by Mesalamine Revenue in 2020
Figure 21. Mesalamine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 22. Global Mesalamine Sales Market Share by Type (2016-2021)
Figure 23. Global Mesalamine Sales Market Share by Type in 2020
Figure 24. Global Mesalamine Revenue Market Share by Type (2016-2021)
Figure 25. Global Mesalamine Revenue Market Share by Type in 2020
Figure 26. Global Mesalamine Sales Market Share by Application (2016-2021)
Figure 27. Global Mesalamine Sales Market Share by Application in 2020
Figure 28. Global Mesalamine Revenue Market Share by Application (2016-2021)
Figure 29. Global Mesalamine Revenue Market Share by Application in 2020
Figure 30. China Mesalamine Sales Growth Rate 2016-2027 (MT)
Figure 31. China Mesalamine Revenue Growth Rate 2016-2027 (US$ Million)
Figure 32. China Mesalamine Market Share in Global Market 2016-2027
Figure 33. China 5 and 10 Largest Mesalamine Players Market Share by Revenue in Mesalamine in 2020
Figure 34. China Mesalamine Revenue Share by Type (2016-2021)
Figure 35. China Mesalamine Revenue Growth Rate by Type in 2016 & 2020
Figure 36. China Mesalamine Revenue Share by Application (2016-2021)
Figure 37. China Mesalamine Revenue Growth Rate by Application in 2016 & 2020
Figure 38. North America Mesalamine Sales Growth Rate 2016-2021 (MT)
Figure 39. North America Mesalamine Revenue Growth Rate 2016-2021 (US$ Million)
Figure 40. North America Mesalamine Sales Market Share by Country in 2020
Figure 41. North America Mesalamine Revenue Market Share by Country in 2020
Figure 42. U.S. Mesalamine Sales Growth Rate (2016-2021) (MT)
Figure 43. U.S. Mesalamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Canada Mesalamine Sales Growth Rate (2016-2021) (MT)
Figure 45. Canada Mesalamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Europe Mesalamine Sales Growth Rate 2016-2021 (MT)
Figure 47. Europe Mesalamine Revenue Growth Rate 2016-2021 (US$ Million)
Figure 48. Europe Mesalamine Sales Market Share by Country in 2020
Figure 49. Europe Mesalamine Revenue Market Share by Country in 2020
Figure 50. Germany Mesalamine Sales Growth Rate (2016-2021) (MT)
Figure 51. Germany Mesalamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 52. France Mesalamine Sales Growth Rate (2016-2021) (MT)
Figure 53. France Mesalamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 54. U.K. Mesalamine Sales Growth Rate (2016-2021) (MT)
Figure 55. U.K. Mesalamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 56. Italy Mesalamine Sales Growth Rate (2016-2021) (MT)
Figure 57. Italy Mesalamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 58. Russia Mesalamine Sales Growth Rate (2016-2021) (MT)
Figure 59. Russia Mesalamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 60. Asia Pacific Mesalamine Sales Growth Rate 2016-2021 (MT)
Figure 61. Asia Pacific Mesalamine Revenue Growth Rate 2016-2021 (US$ Million)
Figure 62. Asia Pacific Mesalamine Sales Market Share by Region in 2020
Figure 63. Asia Pacific Mesalamine Revenue Market Share by Region in 2020
Figure 64. China Mesalamine Sales Growth Rate (2016-2021) (MT)
Figure 65. China Mesalamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 66. Japan Mesalamine Sales Growth Rate (2016-2021) (MT)
Figure 67. Japan Mesalamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 68. South Korea Mesalamine Sales Growth Rate (2016-2021) (MT)
Figure 69. South Korea Mesalamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 70. India Mesalamine Sales Growth Rate (2016-2021) (MT)
Figure 71. India Mesalamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 72. Australia Mesalamine Sales Growth Rate (2016-2021) (MT)
Figure 73. Australia Mesalamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 74. Taiwan Mesalamine Sales Growth Rate (2016-2021) (MT)
Figure 75. Taiwan Mesalamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 76. Indonesia Mesalamine Sales Growth Rate (2016-2021) (MT)
Figure 77. Indonesia Mesalamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 78. Thailand Mesalamine Sales Growth Rate (2016-2021) (MT)
Figure 79. Thailand Mesalamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 80. Malaysia Mesalamine Sales Growth Rate (2016-2021) (MT)
Figure 81. Malaysia Mesalamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 82. Philippines Mesalamine Sales Growth Rate (2016-2021) (MT)
Figure 83. Philippines Mesalamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 84. Vietnam Mesalamine Sales Growth Rate (2016-2021) (MT)
Figure 85. Vietnam Mesalamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 86. Latin America Mesalamine Sales Growth Rate 2016-2021 (MT)
Figure 87. Latin America Mesalamine Revenue Growth Rate 2016-2021 (US$ Million)
Figure 88. Latin America Mesalamine Sales Market Share by Country in 2020
Figure 89. Latin America Mesalamine Revenue Market Share by Country in 2020
Figure 90. Mexico Mesalamine Sales Growth Rate (2016-2021) (MT)
Figure 91. Mexico Mesalamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 92. Brazil Mesalamine Sales Growth Rate (2016-2021) (MT)
Figure 93. Brazil Mesalamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 94. Argentina Mesalamine Sales Growth Rate (2016-2021) (MT)
Figure 95. Argentina Mesalamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 96. Middle East and Africa Mesalamine Sales Growth Rate 2016-2021 (MT)
Figure 97. Middle East and Africa Mesalamine Revenue Growth Rate 2016-2021 (US$ Million)
Figure 98. Middle East and Africa Mesalamine Sales Market Share by Country in 2020
Figure 99. Middle East and Africa Mesalamine Revenue Market Share by Country in 2020
Figure 100. Turkey Mesalamine Sales Growth Rate (2016-2021) (MT)
Figure 101. Turkey Mesalamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 102. Saudi Arabia Mesalamine Sales Growth Rate (2016-2021) (MT)
Figure 103. Saudi Arabia Mesalamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 104. UAE Mesalamine Sales Growth Rate (2016-2021) (MT)
Figure 105. UAE Mesalamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 106. Mesalamine Value Chain
Figure 107. Channels of Distribution
Figure 108. Distributors Profiles
Figure 109. Bottom-up and Top-down Approaches for This Report
Figure 110. Data Triangulation
Figure 111. Key Executives Interviewed
メサラミンの世界市場 2020年 Market Overview The global Mesalamine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.0% in the forecast period of 2020 to 2025 and will expected to reach USD 161.8 million by 2025, from USD 138.5 million in 2019. The Mesalamine market report pr…- メサラジンの世界及び中国市場 Mesalazine, also known as mesalamine or 5-aminosalicylic acid (5-ASA), is a medication used to treat inflammatory bowel disease, including ulcerative colitis and Crohn's disease. It is generally used for mildly to moderately severe disease. It is taken by mouth or rectally. The formulations which ar…
- 世界の高純度メントール市場インサイト・予測（～2027年） Market Analysis and Insights: Global High Purity Menthol Market The global High Purity Menthol market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027. Global High Purity Menthol Scope and Segment High Purity…
- 世界の高純度1,4-ジオキサン市場インサイト・予測（～2027年） Market Analysis and Insights: Global High Purity 1,4-Dioxane Market The global High Purity 1,4-Dioxane market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027. Global High Purity 1,4-Dioxane Scope and Segment…
- 世界の高純度1,4-ジオキサン市場インサイト・予測（～2027年） Market Analysis and Insights: Global High Purity 1,4-Dioxane Market The global High Purity 1,4-Dioxane market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027. Global High Purity 1,4-Dioxane Scope and Segment…